Market Pulse
KIS quote snapshot · Sep 21, 2026 11:00 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
6,984.85
+90.62 (+1.31%)
KOSDAQ
835.91
+8.79 (+1.06%)
KOSPI 200
1,108.10
+17.87 (+1.64%)
USD/KRW
1,383.30
128940KOSPI·Feb 05, 2025
Focus on potential recovery in quarterly earnings and June ADA event
Mirae Asset Securities published a company analysis report on Hanmi Pharm. Co., Ltd. (128940) titled "Focus on potential recovery in quarterly earnings and June ADA event".
Summary
Covers Hanmi Pharm. Co., Ltd. (128940).
Covered stock
More on 128940
Roche��s answer to Eli Lilly and Novo NordiskMirae Asset Securities · Aug 26, 2026Focus on Beijing Hanmi��s recovery and pipeline progressMirae Asset Securities · Jul 29, 2026Eli Lilly deal adds to pipeline valueMirae Asset Securities · Jun 04, 2026Sailing With LillyKB Securities · Jun 02, 2026Initiating Coverage: Core Business Recovery; Obesity, R&D NextKB Securities · May 27, 2026First Korean pharma to translate the obesity theme into earningsMirae Asset Securities · Feb 06, 20262Q25 review: Revenue misses, OP beatsMirae Asset Securities · Jul 29, 2025